Business Description
Mega Genomics Ltd
ISIN : KYG5960G1047
Total Employee Number:
206Compare
Compare
Traded in other countries / regions
06667.Hong Kong IPO Date
2022-06-22Description
Mega Genomics Ltd is a genetic testing platform company in China with a focus on consumer genetic testing and cancer screening services, ancillary services, and related products in the PRC. The company has launched dozens of testing services, covering a wide range of fields such as nutrition and metabolism, cancer risk assessment, chronic disease susceptibility, cancer screening, and infectious disease diagnosis, to meet consumers' growing preventive medical needs. It generates a majority of its revenue from consumer genetic testing services.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 14.89 | |||||
Equity-to-Asset | 0.73 | |||||
Debt-to-Equity | 0.05 | |||||
Debt-to-EBITDA | 0.72 | |||||
Interest Coverage | 27.85 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 5.41 | |||||
Beneish M-Score | -1.06 | |||||
WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 20.6 | |||||
3-Year EPS without NRI Growth Rate | 287.8 | |||||
3-Year FCF Growth Rate | -12.7 | |||||
3-Year Book Growth Rate | 1.4 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 38.96 | |||||
9-Day RSI | 46.53 | |||||
14-Day RSI | 49.53 | |||||
3-1 Month Momentum % | 1.14 | |||||
6-1 Month Momentum % | 1.87 | |||||
12-1 Month Momentum % | -1.39 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.56 | |||||
Quick Ratio | 3.41 | |||||
Cash Ratio | 2.07 | |||||
Days Inventory | 38.84 | |||||
Days Sales Outstanding | 188.27 | |||||
Days Payable | 166.77 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 2.4 | |||||
Dividend Payout Ratio | 0.96 | |||||
Forward Dividend Yield % | 2.4 | |||||
5-Year Yield-on-Cost % | 2.4 | |||||
3-Year Average Share Buyback Ratio | 2.1 | |||||
Shareholder Yield % | 4.72 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 33.72 | |||||
Operating Margin % | 10.95 | |||||
Net Margin % | 6.99 | |||||
EBITDA Margin % | 11.31 | |||||
FCF Margin % | -4.54 | |||||
OCF Margin % | -4.49 | |||||
ROE % | 4.16 | |||||
ROA % | 3.23 | |||||
ROIC % | 14.65 | |||||
3-Year ROIIC % | 699.91 | |||||
ROC (Joel Greenblatt) % | 22.62 | |||||
ROCE % | 5.21 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 47.17 | |||||
PE Ratio without NRI | 39.97 | |||||
PS Ratio | 3.45 | |||||
PB Ratio | 2.27 | |||||
Price-to-Tangible-Book | 2.27 | |||||
EV-to-EBIT | 42.71 | |||||
EV-to-EBITDA | 34.48 | |||||
EV-to-Revenue | 3.9 | |||||
EV-to-FCF | -85.98 | |||||
Price-to-GF-Value | 0.42 | |||||
Price-to-Graham-Number | 2.01 | |||||
| Price-to-Net-Current-Asset-Value | 2.71 | |||||
| Price-to-Net-Cash | 6.87 | |||||
Earnings Yield (Greenblatt) % | 2.34 | |||||
FCF Yield % | -1.16 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Mega Genomics Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 405.907 | ||
| EPS (TTM) (HK$) | 0.15 | ||
| Beta | 0.0347 | ||
| 3-Year Sharpe Ratio | -0.06 | ||
| 3-Year Sortino Ratio | -0.11 | ||
| Volatility % | 1.94 | ||
| 14-Day RSI | 49.53 | ||
| 14-Day ATR (HK$) | 0.104134 | ||
| 20-Day SMA (HK$) | 7.08275 | ||
| 12-1 Month Momentum % | -1.39 | ||
| 52-Week Range (HK$) | 5 - 7.53 | ||
| Shares Outstanding (Mil) | 223.73 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Mega Genomics Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Mega Genomics Ltd Stock Events
| Event | Date | Price (HK$) | ||
|---|---|---|---|---|
| HKD 0.170000 Cash Dividend | 2026-05-26 | 7.10 (+0.00%) |
Show
Entries
Mega Genomics Ltd Frequently Asked Questions
What is Mega Genomics Ltd(HKSE:06667)'s stock price today?
The current price of HKSE:06667 is HK$7.08. The 52 week high of HKSE:06667 is HK$7.53 and 52 week low is HK$5.00.
When is next earnings date of Mega Genomics Ltd(HKSE:06667)?
The next earnings date of Mega Genomics Ltd(HKSE:06667) is .
Does Mega Genomics Ltd(HKSE:06667) pay dividends? If so, how much?
The Dividend Yield %  of Mega Genomics Ltd(HKSE:06667) is 2.4% (As of Today), Highest Dividend Payout Ratio of Mega Genomics Ltd(HKSE:06667) was 0.96. The lowest was 0. And the median was 0. The  Forward Dividend Yield % of Mega Genomics Ltd(HKSE:06667) is 2.4%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Mega Genomics Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers